Guoliang Zheng
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Guoliang Zheng has a total of 81 co-authors. Here are the top co-authors by number of shared publications:
- Can Hu
Department of Gastric Surgery, Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, China
2 shared publications Qing Yang
Department of Gastric Surgery, The Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Institutes of Basic Medicine and Cancer (IBMC), Chinese Academy of Sciences, Hangzhou, 310022, China; Key Laboratory of Prevention, Diagnosis and Therapy of Upper Gastrointestinal Cancer of Zhejiang Province, Hangzhou, 310022, China; Zhejiang Provincial Research Center for Upper Gastrointestinal Tract Cancer, Zhejiang Cancer Hospital, Hangzhou, 310022, China
2 shared publicationsRuolan Zhang
2 shared publicationsXiangdong Cheng
Department of Gastric Surgery, The Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Institutes of Basic Medicine and Cancer (IBMC), Chinese Academy of Sciences, Hangzhou, 310022, China; Key Laboratory of Prevention, Diagnosis and Therapy of Upper Gastrointestinal Cancer of Zhejiang Province, Hangzhou, 310022, China; Zhejiang Provincial Research Center for Upper Gastrointestinal Tract Cancer, Zhejiang Cancer Hospital, Hangzhou, 310022, China
2 shared publicationsXin Xin
Shenyang Mental Health Center Shenyang Liaoning China
2 shared publicationsXin Zhang
Department of Nuclear Medicine Shengjing Hospital of China Medical University Shenyang Liaoning China
2 shared publications
Latest Publications
- Open Access
- 20 July 2026
- Published by Wiley in Advanced Science
- Vol. 13 (54) , e76455
Multiscale Spatial Fusion Feature‐Driven Characterization of Gastric Cancer Invasive Margins: A Multicenter Cohort Study for Preoperative Accurate Differentiation Between T4a and T4b Subtypes
Accurate preoperative differentiation of gastric cancer T4a/b stages is crucial for surgical planning and prognosis. However, conventional CT assessments often yield suboptimal staging accuracy due to visual limitations and inadequate peritumoral microinvasion quantification. This study developed a multi‐scale spatial feature fusion model based on extended regions of interest (eROI) for precise preoperative T4a/b differentiation. We proposed the GAVR model with a three‐tier architecture: a Boundary‐Augmented U‐Net for eROI generation incorporating the peritumoral microenvironment; parallel pathways extracting conventional radiomics, 2D, and 3D deep learning features; and a Vision Transformer for global attention‐weighted fusion and discriminative representation learning. The model was validated across a multicenter cohort of 1804 patients, including internal, external, and prospective sets. A blinded reader study involving 16 radiologists evaluated its clinical utility. GAVR demonstrated exceptional generalizability, achieving AUCs of 0.987 and 0.979 in two independent external sets and 0.987 prospectively. Ablation studies confirmed the necessity of multi‐scale features. GAVR assistance significantly improved radiologists' diagnostic accuracy (0.609 to 0.795) and reduced reading time by 60%. By deeply fusing multi‐scale spatial features, GAVR characterizes structural heterogeneity in complex gastric cancer invasive margins and mitigates overfitting. It demonstrates clear translational value as an embeddable decision‐support tool for multidisciplinary gastric cancer management.
- 20 July 2026
- Published by Wiley in Advanced Science
- Vol. 13 (54) , e76455
Open AccessMultiscale Spatial Fusion Feature‐Driven Characterization of Gastric Cancer Invasive Margins: A Multicenter Cohort Study for Preoperative Accurate Differentiation Between T4a and T4b Subtypes
Accurate preoperative differentiation of gastric cancer T4a/b stages is crucial for surgical planning and prognosis. However, conventional CT assessments often yield suboptimal staging accuracy due to visual limitations and inadequate peritumoral microinvasion quantification. This study developed a multi‐scale spatial feature fusion model based on extended regions of interest (eROI) for precise preoperative T4a/b differentiation. We proposed the GAVR model with a three‐tier architecture: a Boundary‐Augmented U‐Net for eROI generation incorporating the peritumoral microenvironment; parallel pathways extracting conventional radiomics, 2D, and 3D deep learning features; and a Vision Transformer for global attention‐weighted fusion and discriminative representation learning. The model was validated across a multicenter cohort of 1804 patients, including internal, external, and prospective sets. A blinded reader study involving 16 radiologists evaluated its clinical utility. GAVR demonstrated exceptional generalizability, achieving AUCs of 0.987 and 0.979 in two independent external sets and 0.987 prospectively. Ablation studies confirmed the necessity of multi‐scale features. GAVR assistance significantly improved radiologists' diagnostic accuracy (0.609 to 0.795) and reduced reading time by 60%. By deeply fusing multi‐scale spatial features, GAVR characterizes structural heterogeneity in complex gastric cancer invasive margins and mitigates overfitting. It demonstrates clear translational value as an embeddable decision‐support tool for multidisciplinary gastric cancer management.
- Open Access
- 16 July 2026
- Published by Springer Nature in BMC Medical Education
- Vol. 26 (1)
Enhancing nuclear medicine residency standardization training: a comprehensive exploration of integrating a flipped classroom and case-based learning for effective instruction
In universities outside China, particularly in Western countries, flipped classrooms and case-based learning have been used to address drawbacks of traditional teaching. Yet, in China, these models are still under exploration. To investigate the preliminary outcomes and implementation challenges of implementing the flipped classroom combined with CBL teaching model. The study was conducted at the Department of Nuclear Medicine, Shengjing Hospital, China Medical University, and included pre-course study of clinical cases, in-class group presentations, and pre- and post-course teaching assessments. Results revealed a notable improvement in post-course knowledge quiz scores, suggesting promising preliminary outcomes of this integrated teaching approach in this exploratory setting.Trainees praised the participatory and enjoyable nature, fostering a relaxed learning atmosphere. However, some found the pre-course phase time-consuming. This exploratory implementation suggests that the integrated model may deepen trainees' understanding, stimulate independent learning, and improve clinical thinking. Positive feedback highlights its potential value in improving the quality and efficiency of standardized training in nuclear medicine.
- 16 July 2026
- Published by Springer Nature in BMC Medical Education
- Vol. 26 (1)
Open AccessEnhancing nuclear medicine residency standardization training: a comprehensive exploration of integrating a flipped classroom and case-based learning for effective instruction
In universities outside China, particularly in Western countries, flipped classrooms and case-based learning have been used to address drawbacks of traditional teaching. Yet, in China, these models are still under exploration. To investigate the preliminary outcomes and implementation challenges of implementing the flipped classroom combined with CBL teaching model. The study was conducted at the Department of Nuclear Medicine, Shengjing Hospital, China Medical University, and included pre-course study of clinical cases, in-class group presentations, and pre- and post-course teaching assessments. Results revealed a notable improvement in post-course knowledge quiz scores, suggesting promising preliminary outcomes of this integrated teaching approach in this exploratory setting.Trainees praised the participatory and enjoyable nature, fostering a relaxed learning atmosphere. However, some found the pre-course phase time-consuming. This exploratory implementation suggests that the integrated model may deepen trainees' understanding, stimulate independent learning, and improve clinical thinking. Positive feedback highlights its potential value in improving the quality and efficiency of standardized training in nuclear medicine.
- Open Access
- 1 January 2026
- Published by Innovation Press Co., Limited in The Innovation Oncology
- Vol. 1 (2) , 100019-1-100019-2
The value and limits of artificial intelligence in perioperative immunotherapy for gastric cancer
- 1 January 2026
- Published by Innovation Press Co., Limited in The Innovation Oncology
- Vol. 1 (2) , 100019-1-100019-2
Open AccessThe value and limits of artificial intelligence in perioperative immunotherapy for gastric cancer
- 17 September 2025
- Published by Elsevier in European Journal of Surgical Oncology
- Vol. 51 (11) , 110455
Contour-like model for precision risk stratification in gastric cancer patients underwent neoadjuvant therapy: A multicenter retrospective study
- 17 September 2025
- Published by Elsevier in European Journal of Surgical Oncology
- Vol. 51 (11) , 110455
Contour-like model for precision risk stratification in gastric cancer patients underwent neoadjuvant therapy: A multicenter retrospective study
- Open Access
- 23 July 2025
- Published by Springer Nature in npj Precision Oncology
- Vol. 9 (1) , 1-11
Development of a deep learning model for T1N0 gastric cancer diagnosis using 2.5D radiomic data in preoperative CT images
Early detection and precise preoperative staging of early gastric cancer (EGC) are critical. Therefore, this study aims to develop a deep learning model using portal venous phase CT images to accurately distinguish EGC without lymph node metastasis. This study included 3164 patients with gastric cancer (GC) who underwent radical surgery at two medical centers in China from 2006 to 2019. Moreover, 2.5D radiomic data and multi-instance learning (MIL) were novel approaches applied in this study. By basing the selection of features on 2.5D radiomic data and MIL, the ResNet101 model combined with the XGBoost model represented a satisfactory performance for diagnosing pT1N0 GC. Furthermore, the 2.5D MIL-based model demonstrated a markedly superior predictive performance compared to traditional radiomics models and clinical models. We first constructed a deep learning prediction model based on 2.5D radiomics and MIL for effectively diagnosing pT1N0 GC patients, which provides valuable information for the individualized treatment selection.
- 23 July 2025
- Published by Springer Nature in npj Precision Oncology
- Vol. 9 (1) , 1-11
Open AccessDevelopment of a deep learning model for T1N0 gastric cancer diagnosis using 2.5D radiomic data in preoperative CT images
Early detection and precise preoperative staging of early gastric cancer (EGC) are critical. Therefore, this study aims to develop a deep learning model using portal venous phase CT images to accurately distinguish EGC without lymph node metastasis. This study included 3164 patients with gastric cancer (GC) who underwent radical surgery at two medical centers in China from 2006 to 2019. Moreover, 2.5D radiomic data and multi-instance learning (MIL) were novel approaches applied in this study. By basing the selection of features on 2.5D radiomic data and MIL, the ResNet101 model combined with the XGBoost model represented a satisfactory performance for diagnosing pT1N0 GC. Furthermore, the 2.5D MIL-based model demonstrated a markedly superior predictive performance compared to traditional radiomics models and clinical models. We first constructed a deep learning prediction model based on 2.5D radiomics and MIL for effectively diagnosing pT1N0 GC patients, which provides valuable information for the individualized treatment selection.
- 22 August 2023
- Published by Springer Nature in Journal of Cancer Research and Clinical Oncology
- Vol. 149 (16) , 14965-14982
Identification and analysis of methylation signature genes and association with immune infiltration in pediatric acute myeloid leukemia
Background Acute myeloid leukemia (AML) is a common leukemia with low cure rate and poor prognosis among pediatric patients. The regulation of AML immune microenvironment and methylation remains to be explored. Pediatric and adult AML patients differ significantly in epigenetic factors, and the efficiency of treatment modalities varies between the two groups of patients. Methods We collected mRNA, miRNA and DNA methylation data from pediatric AML patients across multiple databases. Differentially expression genes were identified, and a gene–miRNA regulatory network was constructed. Prognostic risk models were established by integrating LASSO and Cox regression, and a nomogram was generated. Based on this model, we investigated tumor-infiltrating immune cells and cell communication, analyzing the biological functions and pathways associated with prognostic factors. Furthermore, the relationships between all prognostic factors and gene modules were explored, and the impact of these factors on treatment modalities was determined. Results We developed an efficient prognostic risk model and identified HOXA9, SORT1, SH3BP5, mir-224 and mir-335 as biomarkers. We validated these findings in an external dataset and observed a correlation between age and risk in pediatric patients. AML samples with lower risk scores have a better prognosis and higher expression of immune-upregulated biomarkers, and have lower immune scores. Furthermore, we detected discrepancies in immune cell infiltration and interactions between high- and low-risk group samples, which affected the efficacy of immunotherapy. We evaluated all prognostic factors and predicted the effect of immunotherapy and medicine. Conclusion This study comprehensively investigated the role of methylation signature genes in pediatric AML at the level of genomes and transcriptomes. The research aims to enhance the risk stratification, prognosis evaluation and assessment of treatment effectiveness of AML patients. This study also highlight the uniqueness of pediatric AML and foster the development of new immunotherapy and targeted therapy strategies.
- 22 August 2023
- Published by Springer Nature in Journal of Cancer Research and Clinical Oncology
- Vol. 149 (16) , 14965-14982
Identification and analysis of methylation signature genes and association with immune infiltration in pediatric acute myeloid leukemia
Background Acute myeloid leukemia (AML) is a common leukemia with low cure rate and poor prognosis among pediatric patients. The regulation of AML immune microenvironment and methylation remains to be explored. Pediatric and adult AML patients differ significantly in epigenetic factors, and the efficiency of treatment modalities varies between the two groups of patients. Methods We collected mRNA, miRNA and DNA methylation data from pediatric AML patients across multiple databases. Differentially expression genes were identified, and a gene–miRNA regulatory network was constructed. Prognostic risk models were established by integrating LASSO and Cox regression, and a nomogram was generated. Based on this model, we investigated tumor-infiltrating immune cells and cell communication, analyzing the biological functions and pathways associated with prognostic factors. Furthermore, the relationships between all prognostic factors and gene modules were explored, and the impact of these factors on treatment modalities was determined. Results We developed an efficient prognostic risk model and identified HOXA9, SORT1, SH3BP5, mir-224 and mir-335 as biomarkers. We validated these findings in an external dataset and observed a correlation between age and risk in pediatric patients. AML samples with lower risk scores have a better prognosis and higher expression of immune-upregulated biomarkers, and have lower immune scores. Furthermore, we detected discrepancies in immune cell infiltration and interactions between high- and low-risk group samples, which affected the efficacy of immunotherapy. We evaluated all prognostic factors and predicted the effect of immunotherapy and medicine. Conclusion This study comprehensively investigated the role of methylation signature genes in pediatric AML at the level of genomes and transcriptomes. The research aims to enhance the risk stratification, prognosis evaluation and assessment of treatment effectiveness of AML patients. This study also highlight the uniqueness of pediatric AML and foster the development of new immunotherapy and targeted therapy strategies.
- Open Access
- 10 January 2023
- Published by Wiley in Journal of Oncology
- Vol. 2023, 1-13
The Interplay between RNA Editing Regulator ADAR1 and Immune Environment in Colorectal Cancer
An abnormality in the regulation of adenosine deaminase acting on RNA (ADAR) enzymes, which catalyzed adenosine-to-inosine (A-to-I) RNA editing, was closely associated with the highly aggressive biologic behavior and poor prognosis in many malignancies. In the present study, we aimed to investigate the relationship among transcript factors-microRNAs regulatory network, immune environment, and ADAR gene in colorectal carcinoma (CRC). The association among the expression levels of ADAR mRNA and copy number variation, methylation, and mutation status were comprehensively analyzed using cBioPortal, Wanderer, and UALCAN databases in CRC datasets. ADAR-transcript factors (TFs) and ADAR-miRNA regulation networks were constructed by Cistrome Cancer and miRWalk2.0, respectively. The full network and subnetworks for ADAR coexpression genes were constructed using the STRING database and visualized by the MCODE module of the Cytoscape app. The relationship between ADAR mRNA expression and the abundance of infiltrating immune cells in CRC patients was explored by the Tumor Immune Estimation Resource, CIBERSORT, and single-gene gene set enrichment analysis (GSEA). ADAR mRNA was elevated and was a cancer essential gene in CRC. ADAR mRNA and transcripts P110 were significantly elevated in CRC compared to normal controls. Low-level methylation in the promoter region and high copy number amplification of ADAR were responsible for high levels of ADAR mRNA expression. ADAR coexpression genes were mainly involved in immunoregulation, especially T-lymphocyte activation. Hub genes, including CD2, CD274, and FASLG, were also significantly upregulated in the ADAR-high group compared to the control group. Besides, M1 macrophages were enriched in the ADAR-high group compared to the control group. This study demonstrated that ADAR, a new essential gene, was involved in the immune regulator and was a novel immune treatment target in CRC.
- 10 January 2023
- Published by Wiley in Journal of Oncology
- Vol. 2023, 1-13
Open AccessThe Interplay between RNA Editing Regulator ADAR1 and Immune Environment in Colorectal Cancer
An abnormality in the regulation of adenosine deaminase acting on RNA (ADAR) enzymes, which catalyzed adenosine-to-inosine (A-to-I) RNA editing, was closely associated with the highly aggressive biologic behavior and poor prognosis in many malignancies. In the present study, we aimed to investigate the relationship among transcript factors-microRNAs regulatory network, immune environment, and ADAR gene in colorectal carcinoma (CRC). The association among the expression levels of ADAR mRNA and copy number variation, methylation, and mutation status were comprehensively analyzed using cBioPortal, Wanderer, and UALCAN databases in CRC datasets. ADAR-transcript factors (TFs) and ADAR-miRNA regulation networks were constructed by Cistrome Cancer and miRWalk2.0, respectively. The full network and subnetworks for ADAR coexpression genes were constructed using the STRING database and visualized by the MCODE module of the Cytoscape app. The relationship between ADAR mRNA expression and the abundance of infiltrating immune cells in CRC patients was explored by the Tumor Immune Estimation Resource, CIBERSORT, and single-gene gene set enrichment analysis (GSEA). ADAR mRNA was elevated and was a cancer essential gene in CRC. ADAR mRNA and transcripts P110 were significantly elevated in CRC compared to normal controls. Low-level methylation in the promoter region and high copy number amplification of ADAR were responsible for high levels of ADAR mRNA expression. ADAR coexpression genes were mainly involved in immunoregulation, especially T-lymphocyte activation. Hub genes, including CD2, CD274, and FASLG, were also significantly upregulated in the ADAR-high group compared to the control group. Besides, M1 macrophages were enriched in the ADAR-high group compared to the control group. This study demonstrated that ADAR, a new essential gene, was involved in the immune regulator and was a novel immune treatment target in CRC.